reports
- GlobalData Healthcare Department
Innate Pharma SA (IPH) - Financial Analysis Review
Innate Pharma SA (IPH) - Financial Analysis Review Summary Innate Pharma SA (Innate Pharma) is a healthcare products provider that develops immunopharmacology and antibody technology products. The company carries out the discovery and development of therapeutic antibodies for the treatment of cancer and inflammatory diseases. It develops new monoclonal antibodies that targets receptors and pathways in controlling the activation of innate immunity cells. GlobalData's Innate Pharma SA (IPH) - F...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.